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Abstract 
Biocompatible inorganic nanomaterial coating of polymer for biomedical application, 2013, Kicheol 
Yoon, Graduate Program of Chemistry, Ulsan National Institute of Science and Technology (UNIST), 
 
In recent years, zwitterionic polymers has been extensively studied because of their unique water-
stability and highly efficient non-biofouling property. This work describes a new class of polymeric 
ligands for quantum Dot (QD), QDs coated short-chain zwitterionic ligand were stabilized against 
aggregation from proteins. The zwitterionic polymers are synthesized by reversible addition-
fragmentation chain transfer-mediated polymerization to control the uniform molecular weight of 
random copolymer with histidine group for binding QD surface, and (3-(methacryloylamino)propyl)-
dimethyl(3-sulfopropyl)ammonium hydroxide (MPDSAH) group for water solubilization, and 
primary amine group as binding site for derivatization. Then by carefully handling primary amine of 
surface, folate-conjugated QDs (QD-FAs) with high photostability are prepared. We demonstrate 
receptor-mediated conjugation of folic acid functionalized QDs on live cell lines such as Hela cells.  
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Development of Biocompatible Quantum Dots using Zwitterionic 
Copolymer for Biological Application 
 
1. Introduction 
Semiconductor and metallic Nanoparticles (NPs) for application of biomedical imaging have led to 
considerable advances in diagnosis and therapy. Because first, they have unique optical and electronic 
properties and second almost all of the disease processes take place on this length scale.1  
Especially Quantum dots (QDs) are a powerful nanomaterial of photostable fluorophores exhibiting 
high quantum yields with narrow tunable emission wavelengths through visible and near-IR spectra.2-6 
QD’s structures are made up two or more closely positioned quantum dots. One quantum dot has a 
properties like atom. That means, when the quantum dot is atom level, they don’t indicate the specific 
properties. But when the molecular level, they have unique properties. These properties whose 
brightness and stability when the cellular imaging at single molecule level are paramount to typical 
dye and fluorescent protein imaging materials make QDs attractive tools for application of biological 
labeling and optical fluorescent imaging.7-9 Nevertheless, the widespread use of QDs in live cell are 
challenges because of need to five essential QD properties for fluorescence labeling in live cells: 
small size, high stability (both over time and in a wide pH range), high quantum yields, facile 
derivatizabilty, and low nonspecific binding.2 In this study, we have search for enhanced simple 
chemical methods to functionalize NPs in aqueous condition to invent outstanding material systems 
for studying biological phenomena.10 
Most popular non-biofouling materials such as poly(ethylene glycol) (PEG) or oligo(ethylene glycol) 
(OEG) that via grafting surface of nanoparticles widely used to prevent the adsorption of proteins and 
cells in aqueous solution.11-21 However, For long-term applications, PEG is hypersensitive to oxidation 
damage and does not completely eliminate protein adsorption.22-28 A steric exclusion effect and 
hydration are considered as one of the reasons for long PEG polymers to resist nonspecific protein 
adsorption.28-30 The existence of water molecules within the PEG layers is required for protein 
resistance,28, 31 at least 2-3 molecules of water per ethylene glycol unit and up to a maximum of 10 
molecules required for hydration.20, 28 In addition, the stability of PEG is adjusted to presence of 
oxygen and transition metal ions because of oxidation,31, 32 and even though it is able to hinder protein 
adsorption at room temperature, its non-biofouling properties are diminished above 35 ℃.32, 33 
Phosphorylcholine (PC)-based polymer make up the majority of typical mammalian cell surface and 
are known to be effective in reducing the adsorption of protein.32, 34 The zwitterionic phospholipid are 
constituent of the cell membranes, and have remarkable nonthrombogenic property.11, 35 Other 
zwitterionic groups, such as carboxybetaine and sulfobetaie polymer, have recently been studied 
because of their water-solubility and biocompatibilities and showed non-biofouling property.11, 36, 37, 38 
Based on the previous report, We synthesized random copolymers with Histamine acrylate, (3-
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(methacryloylamino)propyl)-dimethyl(3-sulfopropyl)ammonium hydroxide inner salt (MPDSAH) and 
PEG acrylate for QD binding, water solubilization, and functionalization, respectively via Reversible 
Addition-Fragmentation Chain Transfer (RAFT). For this study, Poly(amino-PEG3)10%-
Histamine50%-MPDSAH40% and Poly(amino-PEG3)25%-Histamine50%-MPDSAH25% was 
synthesized respectively, and We compare 10% and 25% functional amine to confirm by probing the 
free amine in the polymer before and after the conjugation using Fluorescein isothiocyanate (FITC), 
an amine-reactive fluorogenic probe.39 
We demonstrate extremely low nonspecific binding on protein and high stability exceptional other 
defect and long lifetime emitting fluorescence, to confirm optical live cell imaging. 
 
2. Results and Discussion 
 
 
 
Scheme 1 Synthesis of monomer. 
 
Synthesis of monomer. Scheme 1 indicate the synthesis of monomers for QD binding and 
derivatization that were used for polymerization. Acrylic acid (1) is connected to primary amine of 
histamine by amide bond forming reaction. First, NHS-ester of acrylic acid (2) was prepared by 
coupling reaction at 4 ℃ for 30 min. The resulting product was confirmed by TLC with comparing 
starting materials. The primary amine of histamine containing imidazole group that is QD binding site 
was reacted with NHS-ester of acrylic acid to yield monomer (3) because the N-Hydroxysuccinimide 
(NHS) is used as an activating reagent for carboxylic acids. The imidazole nitrogen of final monomer 
(4) was protected by BOC group because, when polymerization reaction by using trithiocarbonate 
RAFT agent, the RAFT agent is highly sensitive to amine group toward degradation by aminolysis. 
Likewise, monomer (6) was synthesized initially by BOC protected terminal amines and followed by 
reaction with (2).  
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Scheme 2 Synthesis of Polyzwitterionic Ligand (PZL) by RAFT copolymerization. 
 
Synthesis of zwitterionic random copolymer containing imidazole. For the polymerization of 4, 6, 
7 (Table 1), we adopted a RAFT polymerization method using the trithiocarbonate chain transfer 
agent CTA-1 (8) (Scheme 2). Under the standard conditions ([CTA]:[Monomer]:[AIBN] = 1:56:0.2) 
in methanol (MeOH) at 70 °C in a closed reaction ample. The resulting polymer MWs (9a) were ~ 28 
kDa with RMS Error 1.11 e-04 as measured by SLS.    
Ligand exchange of QD-PZL. Ligand exchange of 605 nm emitting QDs, CdSe/CdZnS core/shell2 
using polyzwitterionic ligand was performed by displacing the part of imidazole groups which can be 
binding interaction with the Zn and Cd rich surface of QDs. The ligand exchange conditions were 
relatively mild and, entailed stirring a mixture of QDs and polyzwitterionic ligand in a solvent of 
chloroform and methanol mixture at 50 ℃ (Scheme 3). The QD-PZLs were dispersed in water or 
PBS and then more purified by filter. 
 
Table 1 Nomenclature of polyzwitterionic ligand used compound. 
 
a Polymer structure can be found in Scheme 1.2. 
 
Nomenclature for PZL Composition in polymer ligand by mole % 
PZL 50% cmpd 4/ 50% cmpd 7 
PZ(aminoPEG3)10% 50% cmpd 4/ 10% cmpd 6/ 40% cmpd 7 
PZ(aminoPEG3)25% 50% cmpd 4/ 25% cmpd 6/ 25% cmpd 7 
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Scheme 3 Ligand exchange of QD by polyzwitteronic ligand. 
 
UV spectra measurement. The Absorbance peak of QD-PZL, QD-PZ(aminoPEG3)10% and QD-
PZ(aminoPEG3)25% exhibited slight red-shift (Table 2). The fluorescence also was designated other 
place (figure 1). 
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Table 2 QD UV spectra as a % amine function in polymer. 
 
a Comparison of absorbance spectra peaks and fluorescence peaks before/after coated polyzwitterionic polymer 
of various compositions. 
 
 
 
 
 
 
 
 
 
 
 
 
QD sample Absorbance (nm) Fluorescence (nm) 
QD 601 605 
QD-PZL 598 613 
QD-PZ(aminoPEG3)10% 596 611 
QD-PZ(aminoPEG3)25% 595 604 
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Figure 1 Absorption spectra QD-PZL (━ red), QD-PZ(aminoPEG3)10% (━ blue), QD-
PZ(aminoPEG3)25% (━ Black) and emission spectra QD-PZL (--- red), QD-PZ(aminoPEG3)10% (--- 
blue, QD-PZ(aminoPEG3)25% (--- black) of QDs after ligand exchange in water, showing a slight shift 
in fluorescence intensity to depend on the functional modified ligand. 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
Water-stability measurement by DLS and TEM. QD-PZLs size distributions were imaged by 
DLS. QD-PZL particle size was around 7.877 nm without showing other specific peak. QD-
PZ(aminoPEG3)10% and QD-PZ(aminoPEG3)25% was measured at the next step. Each particle size was 
measured as 10.19 nm and 26.75 nm respectively. The particle sizes were increased with amount of 
amine part without regularity. And we measured DLS of QD-PZ(aminoPEG3)10% and QD-
PZ(aminoPEG3)25% one more time after conjugating folic acid. Because we hypothesize that the 
functional amine aggregated each other particles. So we demonstrated mechanism of functional amine 
on the surface of QDs by protected functional amine used folic acid. Folic acid conjugated QD-PZLs 
size distribution was indicated about 7.99nm and 17.39 nm respectively. In the result, the folic acid 
conjugated QD-PZLs were indicated to decrease the particle size less than QD-PZ(aminoPEG3) 
without folic acid. We concluded that functional amine affect the aggregation between particles 
(Figure 2A). The stability of QD-PZLs are well dispersed in water and PBS (Figure 2B). TEM 
analysis of QDs after ligand exchange with polyzwitterionic ligand shows that QDs are well dispersed. 
(Figure 2C). 
Amine assay analysis by UV. To know how many amine functional groups surround per each QD 
surface, we used UV-vis (Wavelength ranges : 175~3,300nm, limit resolution : < 0.048 nm) to 
confirm amine assay. Fluorescent dye FITC was used to the derivatization of amine groups. We 
measured absorbance about three cases, QD-PZ(aminoPEG3) before derivatization, and QD-FITC 
mixture, and QD-FITC after filter. The number of working FITC was calculated by comparing the 
increased absorbance intensity of filtered QD-FITC from pure QD-PZ(aminoPEG3) absorbance. We 
confirmed 38, 47 amine functional groups per particle were attached to per each QD-
PZ(aminoPEG3)10% and QD-PZ(aminoPEG3)25% respectively.  
Zeta potential analysis. We used zeta potential measuring system (220V, 60Hz)to observe 
particle aggregation. Our particles have negative charge when it dispersed in water. In general 
case, particles were said to stable when the magnitude of zeta potential was more than 20 mV. 
Before adding amine, QD-PZLs had -24.8 mV zeta potential which means well dispersed in 
water. And zeta potential was tend to increase with adding amine part in polymerization step. 
After adding 10 % mole percent amine part, zeta potential was increased to -12.6 mV. And at 
25 %, zeta potential was -5.0 mV (Figure 4).  We can confirm amine parts enhanced 
aggregation of particles. 
pH stability. To find suitable pH for stability of dispersed QD-PZL in water, DLS of particles 
comparing with QD-PIL2 were measured. As shown in Figure 5, the QD-PIL had increase size at pH 
lower than 5, whereas the QD-PZL had linear size without variation in the whole pH range.  
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Figure 2 Size analysis of polyzwitterionic QDs. (A) Dynamic light scattering of QD-PZL (━ red), 
QD-PZ(aminoPEG3)10% (━ blue), QD-PZ(aminoPEG3)25% (━ black), folic acid conjugated QD-
PZ(aminoPEG3)10% (━ cyan), folic acid conjugated QD-PZ(aminoPEG3)25% (━ gray). (B) 
Dispersion of QD-PZLs in water and PBS. (C) TEM of polyzwitterionic ligand exchanged QDs, 
showing monodisperse QD-PZL.    
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Figure 3 Derivatization of amine functional QD-PZL with the fluorescent dye FITC. (A) Absorption 
spectra of unconjugated QD-PZ(aminoPEG3)10% (━ black), QD-PZ(aminoPEG3)10%- FITC mixture (-
-- blue), QD-PZ(aminoPEG3)10%- FITC purified (━ blue). (B) Absorption spectra of unconjugated 
QD-PZ(aminoPEG3)25% (━ black), QD-PZ(aminoPEG3)10%- FITC mixture (--- red), QD-
PZ(aminoPEG3)10%- FITC purified (━ red) normalized at 598 nm.  
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Figure 4 Zeta potentials of QD-PZL, QD-PZ(aminoPEG3)10%, QD-PZ(aminoPEG3)25% particles 
respectively in water. 
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Figure 5 pH stability of QD-PZL and QD-PIL. 
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Fluorescent imaging of QD-PZL to Hela cells and nonspecific binding property. Non-biofouling 
is needed to reliable targeting and sensing applications involving QDs. To demonstrate the 
nonspecific binding of polyzwitterionic ligand coated QDs, we incubated Hela cells with various 
amine functional group modified QD-PZL and subsequently washed the Hell cells with phosphate-
buffered saline (PBS). The fluorescence images of cells are shown in Figure 6. In case, QD-PZL 
without functional group, which wasn’t conjugated with Folic acid, wasn’t bound at folate receptor of 
Hela cells (Figure 6A). Otherwise, QD-PZL with conjugated folic acid shown the binding folate 
receptor of Hela cells, consistent with an increase in the amount of amines on the QD surface. The 
folate was conjugated to functional amine on the surface of QD-PZLs using EDC/NHS coupling 
chemistry. We incubated Hela cells with QDs (400 mg/ml) of modified functional amine number (0, 
10, 25% of amine, respectively) for 12 h (Figure 6B, C). 
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Figure 6 Fluorescent images of folate receptor of Hela cells labeled QD-PZL with folic acid. (A) 
Non-biofouling of polyzwitterionic ligand exchanged QDs without functional site on Hela cells. (B) 
Folate receptor targeted QD-PZ(aminoPEG3)10%-FAs and (C) Folate receptor targeted QD-
PZ(aminoPEG3)25%-FAs, Fluorescent image of Hela cells with 488 nm excitation, 480 – 600 nm 
emission scan. All images are scaled to the same contrast with scale bar 20 um). 
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3. Summary 
In this study, we demonstrated that Polyzwitterionic (MPDSAH) ligand-coated QDs were a 
promising materials for application of bio-imaging such as diagnosis. Our creation is comparable to 
the previously report for resisting the nonspecific adsorption of protein and highly stable condition. To 
demonstrate conjugation efficiencies of the amide bond on QDs, zwitterionic ligand coted QDs with 
functional amine were conjugated with FITC. To confirm coupling yield through knowledge of the 
extinction coefficients of the dye and QDs and measurement of the product absorption spectra.39 The 
number of FITC 521 nm dye molecules conjugated to the functional amine of QD-PZLs were 
concentrated to 20-fold excess molar ratio (dye/QDs) led to saturation coupling yield of 75% 
conjugated dye and 40% conjugated dye at QD-PZLs with 25% and 10% functional amine 
respectively. 
To test the use of the Folate labeled QD-PZLs for biological imaging, where the cultured Hela cell 
lines folate receptors overexpressed on the surface of human cancer cells. In the results, we 
demonstrated the nonspecific binding to a human cell line as a zwitterionic ligand on QD surface 
without functional amine. And we demonstrated working of many amine function on QD surface. 
In conclusions, we have examined that RAFT synthesized polyzwitterionic ligand is able to ligand 
exchange method for conjugation of QDs for stabilization in aqueous condition and to confirm 
working the functional amine on the QD surface. In this method, hydrophobic surface QDs were 
fabricated by ligand exchanging zwitterionic ligand which was a known non-biofouling polymer. This 
characteristic structure not only protects the QDs but also provides biological imaging applications.  
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4. Experimental 
General Method. We purchased all chemicals from Sigma-Aldrich or Fischer Scientific Chemical 
Company, except stated in the following. The AIBN was purified by recrystallization from methanol 
at 40 ℃ and dried. Polymerization was started with polymerization radical initiator 2,2’-
azobisisobutyronitrile (AIBN) and controlled with molecular weight controlling agent Reversible 
addition–fragmentation chain-transfer polymerization (RAFT). RAFT agent grows in a nearly 
uniform size. For each polymerization, ‘Each monomer’ ratio was varied while checking the polymer 
molecular weight and characteristics. All reactions were performed under Ar unless otherwise noted. 
NMR spectra were recorded on a Varian VNMRS 600 spectrometer with CDCl3 and D2O as a solvent. 
THF was distilled over Na/benzophenone before use. Toluene and DMF was distilled over CaH2. 
Transmission electron microscopy (TEM) was performed on a JEM-1400 that made in JEOL, Japan 
having 120 kV acceleration voltages, 0.38 nm Lattice resolution, 0.20 nm point resolution, and EDS 
resolution 132 eV, to confirm aggregation per each step. Sample specimens were prepared by placing 
a drop of the solution on a carbon-coated Cu grid (200 mesh, EM science). After 30 min, the 
remaining solution on a grid was removed with a filter paper, and the grid was air-dried for 8 h. 
Dynamic light scattering (DLS) experiments were carried out on a BI-200SM equipped with a diode 
laser (637 nm, 4 mW). All DLS data were handled on a Dispersion Technology Software (Brookhaven 
Instruments). Optical density of the solutions was measured on a on a JASCO V-670 UV-Vis 
spectrophotometer equipped with a thermostat sample holder with a magnetic stirrer. % Transmittance 
at 580 nm was used to calculate the optical transmittance (O.T) of the solution by the following 
equation. O.T = 1 – ((Tbuf – Tsol)/Tbuf) where Tbuf was the % transmission of the buffer at 580 nm and 
Tsol was the % transmittance of the solution at the same wavelength. Confocal Laser Scanning 
Fluorescence Microscopy (CLSM) was performed on a FluoView 1000 Confocal Microscope 
(Olympus).  
Synthesis of Acrylic NHS. Acrylic NHS is previous step compound used in synthesizing BHA and 
BPA. First, a solution of dicyclohexyl-carbodiimide (DCC) (5.145 g, 24.975 mmol) in 15 mL dry THF 
was added dropwise to a solution of Acrylic acid (1.50 g, 20.82 mmol) and N-hydroxysuccinimide 
(NHS) (2.865 g, 24.975 mmol) in 60 mL dry THF with stirring at 4 ℃. After dropwise, the solution 
was warmed to the room temperature and stirred 4 h. precipitates were removed by filtration, and 
evaporated in vacuo. Ethylacetate was added to precipitate additional by product, and the solution was 
filtered again. The solvent was evaporated and dissolved in either 10 mL anhydrous DMF or THF to 
create stock solution. 
Synthesis of BOC Histamine Acrylate (BHA). A solution histamine dihydro-chloride (2.5 g, 13.59 
mmol) in 50 mL DMF was added to aqueous solution of Sodium bicarbonate (50 mL, 0.3 M). Acrylic 
NHS prepared in previous synthesize was added dropwise with stirring at 4 ℃. After dropwise, the 
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solution was warmed to room temperature and monitored with silica TLC by ninhydrin stain for 12 h. 
The precipitates were removed by filter. The product was evaporated in vacuo and redissolved in 50 
mL of DMF. Additional filter was needed and triethylamine (2.27 mL, 16.3 mmol) was added to the 
filtered solution. Ditert-butyl dicarbonate was added dropwise with stirring at 4 ℃ and the reaction 
was remained overnight at room temperature. Proper amount of water was added to separate DMF 
from crude solution, and the solution was extracted with CHCl3 (4 × 20 mL). Magnesium sulfate was 
used to dry water, and the solvent removed in vacuo. The pure product was obtained by silica column 
(Change the ratio of ethyl acetate/hexanes gradient). 1H NMR (600 MHz, CDCl3) δ (ppm) 7.92 (s, 
1H), 7.15 (s, 1H), 6.24 (dd, J1 = 1.8 Hz, J2 = 17.0 Hz, 1H), 6.10 (dd, J1 = 9.8 Hz, J2 = 17.0 Hz, 1H), 
5.60 (dd, J1 = 1.8 Hz, J2 = 10.0 Hz, 1H), 3.61 (dt, 2H), 2.70 (t, 2H), 1.55 (s, 9H) . 
Synthesis of BOC PEG Acrylate (BPA). Ditert-butyl dicarbonate (1.98 g, 9.09 mmol) was added 
dropwise to a solution of 4,7,10-trioxa-1,13-tridecanediamine (10.00 g, 45.45 mmol) in DCM (25 mL) 
with stirring at 4 ℃. After dropwise, the solution was warmed to room temperature and stirred 
overnight. The solution was worked up with water (3 × 20 mL) to remove unreacted reagent. 
Magnesium sulfate was used to dry water and solvent evaporated in vacuo. The cure product (2.53 g, 
11.51 mmol) was dissolved in a mixture of sodium bicarbonate (13.3 mL, 0.3 M), and DMF (13.3 
mL). To the solution, Acrylic NHS was added dropwise with stirring at 4 ℃. The reaction was 
monitored with silica TLC by ninhydrin stain for 2h. Proper amount of water was added to separate 
DMF from crude solution, and the solution was extracted with CHCl3 (4 × 20 mL). Magnesium sulfate 
was used to dry water, and the solvent removed in vacuo. The pure product was obtained by silica 
column (Change the ratio of ethyl acetate/hexanes gradient). H-NMR was used to confirm the result 
of final product. 1H NMR (600 MHz, CDCl3) δ (ppm) 6.23 (dd, J1 = 2.0 Hz, J2 = 17.0 Hz, 1H), 6.10 
(dd, J1 = 9.8 Hz, J2 = 17.0 Hz, 1H), 5.59 (dd, J1 = 2.0 Hz, J2 = 9.8 Hz, 1H), 3.66-3.45 (m, 14H), 3.20 
(t, 2H), 1.82-1.75 (m, 4H), 1.42 (s, 12H).  
Synthesis of 2-(Dodecylthiocarbonothioylthio)-2-methylpropanoic acid (TC)41 TC was purchased 
from Aldrich and also synthesized by the literature method 
Synthesis of TC-terminated poly(ethylene glycol) (PEG-CTA)42 TC (7.2 g, 20 mmol) and oxalyl 
chloride (8.6 mL, 100mmol) were added into 40mL dry CH2Cl2 and stirred at room temperature until 
gas evolution stopped. Excess reagents were then removed under vacuum, and the residue was 
redissolved in 80 mL dry CH2Cl2, followed by addition of methoxy poly(ethylene glycol) (Mn = 2000 
g/mol) (8 g, 4 mmol in 100mL dry CH2Cl2). The reaction was stirred for 24 h at room temperature and 
the mixture was concentrated before precipitation from an excess of cold Et2O. The crude polymer 
obtained by filtration was purified by redisolving in CH2Cl2, precipitated in Et2O, and dried under 
vacuum overnight. Yellow powder was obtained. 1H NMR (600 MHz, CDCl3) δ 4.25 (t, 2H), 3.64(m, 
178H), 3.38 (s, 3H), 3.26 (t, 2H), 1.70 (s, 6H), 1.23-1.40 (m, 20H), 0.88 (t, 3H). 
18 
 
Polymerization. Stock solution of monomers BPA (45 mg, 0.125 mmol, in EtOAc), MPDSAH (36.5 
mg, 0.125 mmol, in MeOH), BHA (66 mg, 0.250 mmol, in EtOAc), RAFT agent (20.7944 mg, 0.0088 
mmol, in MeOH) were added in ampule. The solvent was removed in vacuo and AIBN (0.3 mg, 
0.0018 mmol, in MeOH) were added with anhydrous methanol (1 mL). The ampule was subjected to 
4 cycles of freeze-pump-thaw, and sealed under vacuum state using a butane torch. The ampule was 
heated at 70 ℃ in oil bath for overnight. Crude polymer was washed with hexane and minimum of 
mixture ethyl ether and methanol. 4 M HCl in dioxane solution was added to cleave the BOC 
protecting groups. After 1h deprotection, the HCl was removed in vacuo. The deprotected polymer 
was dissolved in water and a solution of NaOH in MeOH (1 M) was added dropwise to adjust the pH 
to be near 7-8. The solvent was removed in vacuo, and then the product was dissolved in water and 
the solution was filtered through a 0.2 um cellulose syringe filter. Polymerization was repeated while 
varying monomer ratio, BPA : MPDSAHIS : BHA = 1 : 4 : 5.  
Ligand Exchange with PZL. QDs (5 mg) were precipitated using MeOH and brought into 100 μL of 
CHCl3. The QD stock solution was mixed with polymer of PZL (100 mg) and stirred for 30 min at RT 
after which 100 μL of water was added followed by stirring for an additional 120 min at 50 ℃ in oil 
bath. QD-PZLs in solvent were precipitated by the addition of ethanol (100 μL), CHCl3 (100 μL), and 
excess hexanes for washing. The samples were centrifuged at 4000 rpm for 2 min. The clear 
supernatant was discarded, and the pellet dried in vacuo, followed by the addition of PBS (500 μL, pH 
7.4). The aqueous sample was then filtered through a 0.2 μm syringe filter before use. 
Measure Mw with Static Light Scattering (SLS). We used SLS to measure molecular weight of 
polymer rather than GPC because the zwitterionic polymer was dissolved in only water. SLS is 
technique measuring the intensity of scattered light to obtain the average molecular Wight Mw of a 
polymer. We obtained refractive index value dc/dn = -1.773e-02 from BI-DNDC technique measured 
each sample stocks (1~5 mg/mL). Following we obtained the molecular weight Mw=2.8×10
4 g/mol 
from Zimm plot technique.  
In vitro assay Hela cell Labeling. Hela cells were propagated in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with FBS (Fetal Bovine Serum 10%) and PS 
(Penicillin/Streptomycin 1%). Then the cultured cells were trypsinized and resuspended in the DMEM 
at a concentration of about 2 × 104 cells/ml. The cell suspension (500 uL) was transferred to each 
Chambered Coverglass (8 units). After 24 h of incubation, the cells were carefully rinsed with PBS. 
For each Chamber, the DMEM medium (500 uL) and the folic acid conjugated QDs (400 ug/mL) 
were added and incubated for 12 h. After 12 h, the QD-PZ(aminoPEG3)-FAs labeled cells were 
carefully rinsed with PBS to remove unbounded QD-PZ(aminoPEG3)-FAs, and fresh DMEM medium 
(500 uL) was added to each chamber for cellular viability. The fluorescent imaging of live Hela cells 
was performed on an FV1000 with SIM and Live fluorescence microscope (Olympus).
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Figure 7 1H-NMR spectrum of compound 4, 6. 
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